Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person UniProt:P08686 CYP21A2

Class:IdReferenceGeneProduct:52702
_chainChangeLogchain:1-494 added on Sat February 7 2015;chain:1-494 for 52702 removed on Mon Feb 26 2024;chain:1-495 for 52702 added on Mon Feb 26 2024
_displayNameUniProt:P08686 CYP21A2
_timestamp2025-02-21 18:55:24
chainchain:1-495
checksumCE5C4EE9D3A0851C
commentFUNCTION A cytochrome P450 monooxygenase that plays a major role in adrenal steroidogenesis. Catalyzes the hydroxylation at C-21 of progesterone and 17alpha-hydroxyprogesterone to respectively form 11-deoxycorticosterone and 11-deoxycortisol, intermediate metabolites in the biosynthetic pathway of mineralocorticoids and glucocorticoids (PubMed:10602386, PubMed:16984992, PubMed:22014889, PubMed:25855791, PubMed:27721825). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:25855791).CATALYTIC ACTIVITY progesterone + reduced [NADPH--hemoprotein reductase] + O2 = 21-hydroxyprogesterone + oxidized [NADPH--hemoprotein reductase] + H2O + H(+)CATALYTIC ACTIVITY 17alpha-hydroxyprogesterone + reduced [NADPH--hemoprotein reductase] + O2 = 11-deoxycortisol + oxidized [NADPH--hemoprotein reductase] + H2O + H(+)COFACTOR The leucine-rich hydrophobic amino acid N-terminal region probably helps to anchor the protein to the microsomal membrane.POLYMORPHISM Several non deleterious alleles have been described including CYP21A2*1A, CYP21A2*1B, CYP21A2*2, CYP21A2*3, CYP21A2*4, CYP21A2*5 and CYP21A2*6. Deleterious alleles are mostly generated by recombinations between CYP21A2 and the pseudogene CYP21A1P through gene conversion. This process consists of recombination events that either delete CYP21A2 or transfer deleterious mutations from CYP21A1P to CYP21A2.DISEASE The disease is caused by variants affecting the gene represented in this entry.SIMILARITY Belongs to the cytochrome P450 family.
descriptionrecommendedName: fullName evidence="64"Steroid 21-hydroxylase ecNumber evidence="33 43 45 46"1.14.14.16 alternativeName: 21-OHase alternativeName: Cytochrome P-450c21 alternativeName: Cytochrome P450 21 alternativeName: Cytochrome P450 XXI alternativeName: Cytochrome P450-C21 alternativeName: Cytochrome P450-C21B
geneNameCYP21A2
CYP21
CYP21B
identifierP08686
isSequenceChangedFALSE
keyword3D-structure
Alternative splicing
Congenital adrenal hyperplasia
Disease variant
Endoplasmic reticulum
Heme
Iron
Lipid metabolism
Lipid-binding
Membrane
Metal-binding
Microsome
Monooxygenase
Oxidoreductase
Proteomics identification
Reference proteome
Steroid-binding
Steroidogenesis
modified[InstanceEdit:84067] Schmidt, EE, 2003-12-18 04:29:09
[InstanceEdit:143527] Schmidt, EE, 2004-11-12 07:45:10
[InstanceEdit:217385] Schmidt, EE, 2008-03-27 06:23:53
[InstanceEdit:354386] Schmidt, EE, 2008-06-18 04:45:12
[InstanceEdit:384350] Kanapin, AA, 2008-11-26 14:00:39
[InstanceEdit:392885] Kanapin, AA, 2009-03-09 12:07:18
[InstanceEdit:400710] Schmidt, EE, 2009-03-25 05:33:35
[InstanceEdit:423310] Kanapin, AA
[InstanceEdit:435478] Kanapin, AA
[InstanceEdit:435871] Kanapin, AA
[InstanceEdit:447347] Kanapin, AA
[InstanceEdit:525883] Kanapin, AA
[InstanceEdit:613449] Kanapin, AA
[InstanceEdit:797602] Kanapin, AA
[InstanceEdit:937368] Yung, CK
[InstanceEdit:1042053] Yung, CK
[InstanceEdit:1220657] Yung, CK
[InstanceEdit:1300696] Yung, CK
[InstanceEdit:1301627] Yung, CK
[InstanceEdit:1551960] Weiser, JD
[InstanceEdit:1995863] Weiser, JD
[InstanceEdit:2132304] Weiser, JD
[InstanceEdit:2265580] Weiser, JD
[InstanceEdit:2587579] Weiser, JD
[InstanceEdit:3445779] Weiser, JD
[InstanceEdit:4341137] Weiser, JD
[InstanceEdit:5433710] Weiser, JD
[InstanceEdit:5618415] Weiser, JD
[InstanceEdit:5634237] Weiser, JD
[InstanceEdit:5673015] Weiser, JD
[InstanceEdit:8856987] Weiser, JD
[InstanceEdit:8869714] Weiser, JD
[InstanceEdit:8964659] Weiser, JD
[InstanceEdit:8987656] Weiser, JD
[InstanceEdit:9037114] Weiser, JD
[InstanceEdit:9637257] Weiser, JD
[InstanceEdit:9676415] Weiser, JD
[InstanceEdit:9715482] Weiser, JD
[InstanceEdit:9730071] Weiser, JD
[InstanceEdit:9767224] Weiser, Joel
[InstanceEdit:9852000] Weiser, Joel, 2023-11-03
[InstanceEdit:9862192] Weiser, Joel, 2024-02-26
[InstanceEdit:9909836] Weiser, Joel, 2024-05-14
[InstanceEdit:9917590] Weiser, Joel, 2024-08-09
[InstanceEdit:9926675] Weiser, Joel, 2024-11-03
[InstanceEdit:9939033] Weiser, Joel, 2025-02-21
nameCYP21A2
referenceDatabase[ReferenceDatabase:2] UniProt
referenceGene[ReferenceDNASequence:8992971] ENSEMBL:ENSG00000231852 CYP21A2 [Homo sapiens]
secondaryIdentifierCP21A_HUMAN
A2BHY6
P04033
Q01204
Q08AG8
Q16749
Q16806
Q16874
Q5ST44
Q96NU8
sequenceLength495
species[Species:48887] Homo sapiens
(isoformParent)[ReferenceIsoform:8972760] UniProt:P08686-1 CYP21A2 [Homo sapiens]
[ReferenceIsoform:8972761] UniProt:P08686-2 CYP21A2 [Homo sapiens]
(referenceEntity)[EntityWithAccessionedSequence:194028] CYP21A2 [endoplasmic reticulum membrane] [Homo sapiens]
[EntityWithAccessionedSequence:5601934] CYP21A2 E380D [endoplasmic reticulum membrane] [Homo sapiens]
[EntityWithAccessionedSequence:5601937] CYP21A2 W406* [endoplasmic reticulum membrane] [Homo sapiens]
[EntityWithAccessionedSequence:5601946] CYP21A2 G292S [endoplasmic reticulum membrane] [Homo sapiens]
[EntityWithAccessionedSequence:5601956] CYP21A2 Q318* [endoplasmic reticulum membrane] [Homo sapiens]
[EntityWithAccessionedSequence:5601986] CYP21A2 V237E [endoplasmic reticulum membrane] [Homo sapiens]
(referenceSequence)[ReplacedResidue:5601939] glycine 292 replaced with L-serine
[ReplacedResidue:5601942] L-valine 237 replaced with L-glutamic acid
[NonsenseMutation:5601974] Nonsense mutation at L-tryptophan 406
[ReplacedResidue:5601982] L-glutamic acid 380 replaced with L-aspartic acid
[NonsenseMutation:5601983] Nonsense mutation at L-glutamine 318
[Change default viewing format]
No pathways have been reviewed or authored by UniProt:P08686 CYP21A2 (52702)